Grade: Pharmaceutical Grade

Factory Location: JIANGXI

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: yes

Payment Terms: L/L

Elagolix Soidum (NBI-56418, ABT-620) 是一种有效的、选择性的、具有口服活性的促性腺激素释放激素受体GnRHR非肽段拮抗剂，Kd值为54 pM。浓度为10 μM时，对离子通道、酶和转运体没有显著的活性作用(inhibition <50%)。